tm logo

Monitor this mark

View On USPTO

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX
Live/Registered
REGISTERED

on 11 May 2021

Last Applicant/ Owned by

OSRX, Inc.

1120 Kensington Ave., Suite E

Missoula

MT

59801

Serial Number

88423698 filed on 09th May 2019

Registration Number

6348820 registered on 11th May 2021

in the Principal Register

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman

650 Page Mill Road

Palo Alto CA 94304

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX

Ophthalmic preparations containing TIMOLOL, BRIMONIDINE TARTRATE, DORZOLAMIDE, and LATANOPROST

Classification Information

Class [005]
Pharmaceutical Products

Ophthalmic preparations containing TIMOLOL, BRIMONIDINE TARTRATE, DORZOLAMIDE, and LATANOPROST

First Use Date in General

01st May 2019

First Use Date in Commerce

01st May 2019

Mark Details

Serial Number

No 88423698

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 56390-TM1017

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.06 -

Semi-circles

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History

Show more

Status DateAction Taken
11th May 2021REGISTERED-PRINCIPAL REGISTER
07th Apr 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06th Apr 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05th Apr 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
05th Apr 2021TEAS/EMAIL CORRESPONDENCE ENTERED
05th Apr 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
06th Oct 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
06th Oct 2020NON-FINAL ACTION E-MAILED
06th Oct 2020SU - NON-FINAL ACTION - WRITTEN
02th Oct 2020STATEMENT OF USE PROCESSING COMPLETE